Offer Request Form

Order list is empty

Why and How to Test Biological Drugs-2

Why and How to Test Biological Drugs-2

EXAMPLE CASE: LAURA STEVENS

Patient: Laura Stevens

Forty-seven years old, high school teacher for over 20 years.

"Three years ago, I was diagnosed with Non-Hodgkin's Lymphoma after experiencing prolonged fatigue, swollen lymph nodes, and unexplained weight loss. My oncologist started me on a chemotherapy regimen that included Rituximab. Initially, the treatment seemed effective; my symptoms started to improve, and my scans showed a reduction in lymph node size. However, after about a year, my progress plateaued, and my symptoms began to worsen again. My oncologist was concerned about the possibility of drug resistance and ordered tests to measure the trough levels of Rituximab and check for anti-drug antibodies using Matriks Biotek kits. These tests indicated low trough levels and the presence of anti-drug antibodies, suggesting that my body might be developing resistance to Rituximab. To combat this, my oncologist replaced Rituximab with Pembrolizumab to my treatment regimen to help boost my immune response against the cancer cells. It's been several months since the addition, and I've felt a significant improvement in my health."

Physician: "Laura has been under my care since her diagnosis with Non-Hodgkin's Lymphoma. We started with a Rituximab-based therapy, which initially showed promising results. However, as Laura began to experience a relapse of symptoms, we decided to check the trough levels of Rituximab and measure anti-drug antibodies using Matriks Biotek kits, which provide reliable and precise measurements. These tests revealed decreased levels of the drug and confirmed the presence of anti-drug antibodies, indicating a potential resistance. In response, we introduced Pembrolizumab to enhance her immune system's ability to fight the cancer. Since adjusting her treatment plan, Laura's response has been encouraging, with significant improvements observed. The measurement of trough and anti-drug antibodies is very important to use the drug effectively and safely. For this purpose, we always choose Matriks Biotek kits for accurate results."

Laboratory official: "In oncology, precise monitoring of drug levels and the detection of anti-drug antibodies can be crucial for determining the effectiveness of treatment and making necessary adjustments. For Laura's case, we used Matriks Biotek kits to measure the trough levels of Rituximab and to check for anti-drug antibodies. These kits are essential for providing accurate data that help in assessing how patients metabolize and respond to their treatment. This information allowed her oncologist to tailor her therapy, changing the drug to Pembrolizumab after identifying a decrease in Rituximab levels and the presence of anti-drug antibodies. Our role in using advanced diagnostics helps ensure that treatments remain effective and patient outcomes are optimized."

* The names mentioned in this story are fictious and do not reflect real people.